PDE 10a inhibitors for the treatment of type II diabetes
US9193736B2 · kind B2 · utility
6Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2014 |
| Grant date | Nov 24, 2015 |
| Priority date | — |
| Expiry date | Jun 9, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds, compositions and methods for treating Type II diabetes. Such compounds are represented by Formula (I) as follows:wherein R1, R2, L, and Q are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.